- Home
- PLSM vs AIFA Comparison
PLSM vs AIFA Comparison
Compare PLSM & AIFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLSM | AIFA |
|---|---|---|
| Founded | 2014 | N/A |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.7M | 14.7M |
| IPO Year | 2025 | 2017 |
Fundamental Metrics
Financial Performance| Metric | PLSM | AIFA |
|---|---|---|
| Price | $2.22 | $2.99 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 44.8K | ★ 53.3K |
| Earning Date | 03-30-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $7,655,039.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 20.50 |
| 52 Week Low | $2.26 | $1.52 |
| 52 Week High | $12.97 | $3.45 |
Technical Indicators
Market Signals| Indicator | PLSM | AIFA |
|---|---|---|
| Relative Strength Index (RSI) | 31.47 | 57.00 |
| Support Level | N/A | $2.72 |
| Resistance Level | $2.88 | $3.25 |
| Average True Range (ATR) | 0.24 | 0.18 |
| MACD | 0.02 | -0.04 |
| Stochastic Oscillator | 19.35 | 61.54 |
Price Performance
Historical ComparisonAbout PLSM Pulsenmore Ltd. Ordinary Shares
Pulsenmore Ltd is an emerging medical device company engaged in the research, development, manufacturing, marketing, and sale of non-invasive portable ultrasound solutions for home use. Its products include the Pulsenmore ES and Pulsenmore FC, along with the early-stage Pulsenmore MC, collectively referred to as Pulsenmore Products, enabling remote ultrasound scans in gynecology and other fields such as pulmonary, cardiology, and urology through telemedicine. The Company operates in a single segment focused on developing and commercializing portable ultrasound technologies, with Israel contributing the majority of its revenue.